期刊
JOURNAL OF CLINICAL INVESTIGATION
卷 122, 期 4, 页码 1529-1540出版社
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI61350
关键词
-
资金
- Bundesministerium fur Bildung rind Forschung [03ZIK041]
- Saxon Ministry of Science and Arts [100066308]
- Deutsche Krebshilfe e.V. [108976]
- Deutsche Forschungsgemeinschaft [Ba1433/5]
- Medical Faculty Carl Gustav Carus, Dresden University of Technology, Germany
Integrin signaling critically contributes to the progression, growth, and therapy resistance of malignant tumors. Here, we show that targeting of beta(1) integrins with inhibitory antibodies enhances the sensitivity to ionizing radiation and delays the growth of human head and neck squamous cell carcinoma cell lines in 3D cell culture and in xenograftecl mice. Mechanistically, dephosphorylation of focal adhesion kinase (FAK) upon inhibition of beta(1) integrin resulted in dissociation of a FAK/cortactin protein complex. This, in turn, downregutatted JNK signaling and induced cell rounding, leading to radiosensitization. Thus, these findings suggest that robust and selective pharmacological targeting of beta(1) integrins may provide therapeutic benefit to overcome tumor cell resistance to radiotherapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据